Substituted 2-aminotetralin for the treatment of depression
Details for Australian Patent Application No. 2004258698 (hide)
International Classifications
Event Publications
16 March 2006 PCT application entered the National Phase
PCT publication WO2005/009425 Priority application(s): WO2005/009425
2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
23 December 2010 Alteration of Name
The name of the applicant has been altered to UCB Pharma GmbH
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004258708-Simulated cigarette which is designed to help quell tobacco addiction
2004258697-Use of rotigotine for the treatment of depression
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser